Eleventa

Eleventa is a developer of medical products aimed at providing treatments for asthma and other inflammatory respiratory diseases. The company's medical products include a small molecule compound, which is an active selective CRTH2 receptor antagonist playing a critical role in the initiation process of allergic inflammation, enabling patients with respiratory diseases to recover more quickly through advanced drugs and treatment methods.